51.   And some Japanese companies continued to fall in price as trade relations between the United States and Japan grew increasingly hostile.

52.   And some small biotechnology companies continued to promise quick cures.

53.   And these companies continue to spread further around the world in their quest for greater revenues.

54.   And the company continues to struggle to recruit and retain minority employees at all levels.

55.   And the company continues to prune its investments.

56.   And the company continues to work for the government, including the INS, for which it runs a detention center in Seattle.

57.   And the company will continue to roll out next-generation add-on services such as video on demand, which has proven wildly popular in trials.

58.   And the software browser companies will continue to play a powerful mediating role.

59.   And while the number of dismissals has fallen and companies continue to have a hard time finding qualified workers, others still resort to layoffs to cut costs.

60.   And while the company continues to find new uses for the drugs and to develop newer versions of them, it has not yet found a third blockbuster.